IL33 and colitis: In a T-cell-driven adoptive transfer (AdTr) colitis mouse model, liraglutide significantly improved disease activity markers, including histological activity in colonic tissue and the colon weight-to-length ratio, likely due to its ability to reduce CCL20, IL-33, and IL-22 [23].